Post by Jan Eryk Umiastowski

CFO, GenSight Biologics (Euronext: SIGHT) | Chairman, Blueballoon Capital — Healthcare & Luxury M&A | Founder, Blue & Sunblue Studio | The Vendôme Note

What luxury gets right about capital, and what capital gets wrong about luxury. A monthly note from 10 Place Vendôme.

Post content